The potential of developing pan‑coronaviral antibodies to spike peptides in convalescent COVID‑19 patients

• Autorzy: Rabets A. , Bila G. , Grytsko R. , Samborskyy M. , Rebets Y. , Vari S.G. , Pagneux Q. , Barras A. , Boukherroub R. , Szunerits S. , Bilyy R.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

coronavirus; COVID-19; severe acute respiratory syndrome-coronavirus-2; antibody; immunoglobulin; spike peptide; ELISA test; patient

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2021
• Tom: 69
• Numer: 1
• Opis fizyczny: Article 5 [7p.], fig.,ref.

Twórcy

autor

Rabets A.

• Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

autor

Bila G.

• Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

autor

Grytsko R.

• Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

autor

Samborskyy M.

• Explogen LLC, Lviv, Ukraine

autor

Rebets Y.

• Explogen LLC, Lviv, Ukraine

autor

Vari S.G.

• International Research and Innovation in Medicine Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA

autor

Pagneux Q.

• University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France

autor

Barras A.

• University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France

autor

Boukherroub R.

• University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France

autor

Szunerits S.

• University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France

autor

Bilyy R.

• Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Identyfikatory

DOI

10.1007/s00005-021-00607-8